A study of 666 localised prostate tumours identified 223 driver regions, many influenced by structural variations ...

As an unexpected histologic finding after transurethral resection of the prostate or radical prostatectomy, the cancer has usually spread beyond the prostate capsule at the time of diagnosis.

EPIDEMIOLOGIC studies on modifiable factors after a prostate cancer (PCa) diagnosis remain inconclusive. Postdiagnosis ...

of the University Hospitals Seidman Cancer Center in Ohio, presented findings on an AI-derived digital pathology-based biomarker for localized prostate cancer. Spratt and his colleagues digitized ...

But other tests, such as imaging scans and additional pathology findings, are typically performed to figure out if any cancer has moved beyond the boundaries of the prostate gland before ...

A study led by UCLA investigators shows that artificial intelligence (AI) could play a key role in improving treatment ...

A new large-scale study co-led by UCLA Health Jonsson Comprehensive Cancer Center investigators provides the strongest ...

Opens in a new tab or window Mutations in BRCA1 do not appear to contribute significantly to the risk of prostate cancer progression, according to DNA test results from 450 prostate cancer specimens.

As Quibim prepares to enter the U.S. market, the FDA clearance serves as a testament to the company's dedication to innovation and excellence in medical imaging. The QP-Prostate system is now ready to ...